134 related articles for article (PubMed ID: 12814989)
1. Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
Borer J; Armstrong P;
Circulation; 2003 Jun; 107(23):e9052. PubMed ID: 12814989
[No Abstract] [Full Text] [Related]
2. [New potency pill. Treating (vascular) bed failure].
MMW Fortschr Med; 2003 Jan; 145(5):51. PubMed ID: 12619215
[No Abstract] [Full Text] [Related]
3. Vardenafil (levitra) for erectile dysfunction.
Med Lett Drugs Ther; 2003 Sep; 45(1166):77-8. PubMed ID: 14506469
[No Abstract] [Full Text] [Related]
4. Oral drug treatment of erectile dysfunction.
Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
[No Abstract] [Full Text] [Related]
5. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
Katsarov M
Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
[No Abstract] [Full Text] [Related]
6. [New PDE-5 inhibitor for treatment of impotence. 9 out of 10 have erections again].
MMW Fortschr Med; 2003 Jun; 145(26):59. PubMed ID: 12916343
[No Abstract] [Full Text] [Related]
7. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
[TBL] [Abstract][Full Text] [Related]
8. [Systemic approach to investigation of levitra efficacy in patients with chronic prostatitis with erectile dysfunction].
Aliaev IuG; Ronkin MA; Esilevskiĭ IuM; Zhuchenko TD; Demidko IuL; Krupinov GE; Shcherbanina VIu
Urologiia; 2005; (2):53-60. PubMed ID: 15989030
[TBL] [Abstract][Full Text] [Related]
9. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease.
Reffelmann T; Kloner RA
Circulation; 2003 Jul; 108(2):239-44. PubMed ID: 12860892
[No Abstract] [Full Text] [Related]
11. PDE-5 inhibitors: current status and future trends.
Masson P; Lambert SM; Brown M; Shabsigh R
Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
[TBL] [Abstract][Full Text] [Related]
12. [Management of erectile dysfunction in the cardiac patient].
Gratzke C; Becker AJ; Park JW; Reich O; Waldkirch E; Schlenker B; Stief CG
Dtsch Med Wochenschr; 2005 Dec; 130(50):2899-903. PubMed ID: 16342015
[No Abstract] [Full Text] [Related]
13. Evaluation of vardenafil and sildenafil on cardiac repolarization.
Morganroth J; Ilson BE; Shaddinger BC; Dabiri GA; Patel BR; Boyle DA; Sethuraman VS; Montague TH
Am J Cardiol; 2004 Jun; 93(11):1378-83, A6. PubMed ID: 15165918
[TBL] [Abstract][Full Text] [Related]
14. FDA approves new drug for treatment of erectile dysfunction in men.
FDA Consum; 2003; 37(5):7. PubMed ID: 14666896
[No Abstract] [Full Text] [Related]
15. Prescribing all phosphodiesterase 5 inhibitors to a patient with erectile dysfunction--a realistic and feasible option in everyday clinical practice--outcomes of a simple treatment regime.
Ströberg P; Hedelin H; Ljunggren C
Eur Urol; 2006 May; 49(5):900-7; discussion 907. PubMed ID: 16564126
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 5 inhibitors for erectile dysfunction.
Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
Kloner RA
Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
[TBL] [Abstract][Full Text] [Related]
18. A consumer's guide to impotence drugs.
Burnett AL
Johns Hopkins Med Lett Health After 50; 2004 Jun; 17(4):6. PubMed ID: 15199888
[No Abstract] [Full Text] [Related]
19. [Therapy of erectile dysfunction. Hard facts support sildenafil].
MMW Fortschr Med; 2003 Sep; 145(35-36):50-1. PubMed ID: 14584211
[No Abstract] [Full Text] [Related]
20. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]